Ambiq Micro's Esaka proposes $1.19M share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Ambiq Micro, Inc. director and officer Fumihide Esaka gave notice of a proposed sale of 25,000 common shares, with an aggregate market value of $1,186,500 and an approximate sale date of November 16, 2026.
The notice states that the shares were and will be received upon exercise of stock options over the next three months and identifies a Rule 10b5-1 plan adopted May 15, 2026. Morgan Stanley Smith Barney LLC is named as broker. Past-three-month entries list sales of 54,821 shares for gross proceeds of $2,572,837.24 and 50,000 shares for $2,489,350.
Key Figures
Key Terms
Rule 10b5-1 regulatory
stock options financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.